AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitamaze M XR 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Biotics Lab Life Services Private Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitamaze M XR 50/500 Tablet

Diabexe Duo XR 50/500 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabexe Duo XR 50/500 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial for effective diabetes control; lifestyle choices significantly influence management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; learn to identify and manage hypoglycemic episodes. This medication isn't suitable for all individuals. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Interactions with other medications are possible; disclose all current medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Uses of Sitamaze M XR 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitamaze M XR 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitamaze M XR 50/500 Tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

Common Side effects of Sitamaze M XR 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitamaze M XR 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the Sitamaze M XR 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Sitamaze M XR 50/500 Tablet works:

Sitamaze M XR 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitamaze M XR 50/500 Tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitamaze M XR 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitamaze M XR 50/500 Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitamaze M XR 50/500 Tablets cautiously, potentially requiring dosage modification under medical supervision. Sitamaze M XR 50/500 Tablets are contraindicated in individuals with severe kidney disease. Consistent monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitamaze M XR 50/500 tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitamaze M XR 50/500 Tablet :

Should you forget a Sitamaze M XR 50/500 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitamaze M XR 50/500 Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Sitamaze M XR 50/500 Tablet

Sitamaze M XR 50/500 tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication enhances blood sugar control when combined with a healthy diet and exercise regimen. Metformin reduces liver glucose production and improves insulin responsiveness, while sitagliptin blocks DPP-4, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitamaze M XR 50/500 Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may manifest as anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some studies.
Sitamaze M XR 50/500 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Individuals with hypersensitivity to Sitamaze M XR 50/500 Tablet constituents or inactive ingredients should not use this medication. This medicine is contraindicated in patients experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamaze M XR 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label or packaging. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitagliptin/Metformin combination tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is uncommon but necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia warrant immediate cessation of Sitagliptin/Metformin and prompt medical attention.
Sitamaze M XR 50/500 tablets contain sitagliptin and metformin, two medications used together to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Sitagliptin works by blocking DPP-4, thereby boosting insulin secretion from the pancreas. This medication is unsuitable for individuals under 18.
Taking Sitamaze M XR 50/500 Tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitamaze M XR 50/500 Tablet constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamaze M XR 50/500 Tablet with alcohol is unsafe and may heighten the risk of developing lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Sitamaze M XR 50/500 Tablets. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Its occurrence is linked to metformin use and thus contraindicated in individuals with renal impairment, the elderly, or those who consume significant amounts of alcohol. Warning signs include muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged Sitamaze M XR 50/500 Tablet use can indeed lead to vitamin B12 deficiency. This medication impedes the body's absorption of vitamin B12 within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 administration, at a minimum of annually, has been proposed by some investigators.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Sitagliptin and Metformin, combined as Sitamaze M XR 50/500 Tablet, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and exercise. Metformin reduces liver glucose production and boosts insulin sensitivity. Sitagliptin's action involves DPP4 enzyme inhibition, promoting increased pancreatic insulin release. This formulation is unsuitable for individuals under 18.
Taking Sitamaze M XR 50/500 Tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients exhibiting hypersensitivity to any Sitamaze M XR 50/500 Tablet constituent should not receive this medication. Its administration is contraindicated in individuals with significant renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamaze M XR 50/500 Tablet with alcohol is unsafe and may raise the risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential complication of Sitamaze M XR 50/500 Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in patients with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged Sitamaze M XR 50/500 Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may manifest as anemia and neurological complications, including peripheral paresthesia (tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some experts.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitamaze M XR 50/500 Tabl...
103
MRP 119
13% off